Company page

Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp. is a public company traded under the ticker KTTA in the American market. With a market capitalization of approximately $16.7 million, the company focuses on developing innovative therapies. Pasithea is dedicated to advancing treatments for central nervous system disorders, aiming to improve patient outcomes.